164 related articles for article (PubMed ID: 14695033)
1. In vitro performance of two common valved holding chambers with a chlorofluorocarbon-free beclomethasone metered-dose inhaler.
Asmus MJ; Coowanitwong I; Kwon SH; Khorsand N; Hochhaus G
Pharmacotherapy; 2003 Dec; 23(12):1538-44. PubMed ID: 14695033
[TBL] [Abstract][Full Text] [Related]
2. In vitro deposition of fluticasone aerosol from a metered-dose inhaler with and without two common valved holding chambers.
Asmus MJ; Liang J; Coowanitwong I; Vafadari R; Hochhaus G
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):204-8. PubMed ID: 11868926
[TBL] [Abstract][Full Text] [Related]
3. In vitro performance characteristics of valved holding chamber and spacer devices with a fluticasone metered-dose inhaler.
Asmus MJ; Liang J; Coowanitwong I; Hochhaus G
Pharmacotherapy; 2004 Feb; 24(2):159-66. PubMed ID: 14998215
[TBL] [Abstract][Full Text] [Related]
4. In vitro characterization of the OptiChamber Diamond valved holding chamber.
Hatley RH; von Hollen D; Sandell D; Slator L
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S24-36. PubMed ID: 25054480
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of aerosol drug output from the OptiChamber and AeroChamber spacers in a model system.
Dalby RN; Somaraju S; Chavan VS; Jarvis D
J Asthma; 1998; 35(2):173-7. PubMed ID: 9576143
[TBL] [Abstract][Full Text] [Related]
6. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA
Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
[TBL] [Abstract][Full Text] [Related]
7. Valved Holding Chambers and In Vitro Metered Dose Inhaler Performance: Effects of Flow Rate and Inhalation Delay.
Liu X; Guo C; Chowdhury B; Starke P; Limb S; Peri P; Schroeder A; Doub W
J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):399-410. PubMed ID: 28846482
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro performance of three small-volume valved holding chambers with beclomethasone/formoterol pressurized metered dose inhaler.
Goncalves TM; Alhanout K; Nicolay A; Dubus JC; de Santana DP; Andrieu V
J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):223-7. PubMed ID: 23094686
[TBL] [Abstract][Full Text] [Related]
9. In vitro comparison of beclomethasone and salbutamol metered-dose inhaler aerosols inhaled during pediatric tidal breathing from four valved holding chambers.
Finlay WH; Zuberbuhler P
Chest; 1998 Dec; 114(6):1676-80. PubMed ID: 9872205
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of particle size distribution of salmeterol administered via metered-dose inhaler with and without valved holding chambers.
Kelly HW; Ahrens RC; Holmes M; Stevens AL; Vandermeer AK; Garris T; Reisner C
Ann Allergy Asthma Immunol; 2001 Dec; 87(6):482-7. PubMed ID: 11770695
[TBL] [Abstract][Full Text] [Related]
11. In vitro effect of a holding chamber on the mouth-throat deposition of QVAR (hydrofluoroalkane-beclomethasone dipropionate).
Rahmatalla MF; Zuberbuhler PC; Lange CF; Finlay WH
J Aerosol Med; 2002; 15(4):379-85. PubMed ID: 12581504
[TBL] [Abstract][Full Text] [Related]
12. A pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times.
Leach CL; Colice GL
J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):355-61. PubMed ID: 20575669
[TBL] [Abstract][Full Text] [Related]
13. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
[TBL] [Abstract][Full Text] [Related]
14. Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber.
Salzman GA; Pyszczynski DR
J Allergy Clin Immunol; 1988 Feb; 81(2):424-8. PubMed ID: 3339197
[TBL] [Abstract][Full Text] [Related]
15. Are valved holding chambers (VHCs) interchangeable? An in vitro evaluation of VHC equivalence.
Dissanayake S; Nagel M; Falaschetti E; Suggett J
Pulm Pharmacol Ther; 2018 Feb; 48():179-184. PubMed ID: 29024795
[TBL] [Abstract][Full Text] [Related]
16. Selecting an accessory device with a metered-dose inhaler: variable influence of accessory devices on fine particle dose, throat deposition, and drug delivery with asynchronous actuation from a metered-dose inhaler.
Wilkes W; Fink J; Dhand R
J Aerosol Med; 2001; 14(3):351-60. PubMed ID: 11693847
[TBL] [Abstract][Full Text] [Related]
17. Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol.
Peyron ID; Britto IL; Benissan LB; Tardieu BZ
Respir Med; 2005 Apr; 99 Suppl A():S20-30. PubMed ID: 15777605
[TBL] [Abstract][Full Text] [Related]
18. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
Wolthers OD; Walters EG
Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
[TBL] [Abstract][Full Text] [Related]
19. Improved targeting of beclomethasone diproprionate (250 micrograms metered dose inhaler) to the lungs of asthmatics with the Spacehaler.
Newman SP; Steed KP; Hooper G; Jones JI; Upchurch FC
Respir Med; 1999 Jun; 93(6):424-31. PubMed ID: 10464826
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three valved holding chambers for the delivery of fluticasone propionate-HFA to an infant face model.
Louca E; Leung K; Coates AL; Mitchell JP; Nagel MW
J Aerosol Med; 2006; 19(2):160-7. PubMed ID: 16796540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
